NCT01990781

Brief Summary

Post operative sore throat (POST) following tracheal intubation is a common problem causing dissatisfaction and discomfort to the patients. Prophylactic use of both lidocaine and dexamethasone has been used independently for this purpose. However, there is no study assessing the synergistic analgesic effects of lidocaine and dexamethasone for POST. The purpose of this study is to compare the effect of lidocaine, dexamethasone and lidocaine dexamethasone combination on the incidence and severity of POST.

Trial Health

87
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
180

participants targeted

Target at P50-P75 for phase_4

Timeline
Completed

Started Dec 2013

Typical duration for phase_4

Geographic Reach
1 country

1 active site

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

First Submitted

Initial submission to the registry

November 2, 2013

Completed
19 days until next milestone

First Posted

Study publicly available on registry

November 21, 2013

Completed
10 days until next milestone

Study Start

First participant enrolled

December 1, 2013

Completed
2 years until next milestone

Primary Completion

Last participant's last visit for primary outcome

December 1, 2015

Completed
1 month until next milestone

Study Completion

Last participant's last visit for all outcomes

January 1, 2016

Completed
Last Updated

November 7, 2016

Status Verified

November 1, 2016

Enrollment Period

2 years

First QC Date

November 2, 2013

Last Update Submit

November 4, 2016

Conditions

Keywords

Lidocaine, Dexamethasone, Postoperative sore throat

Outcome Measures

Primary Outcomes (1)

  • Assessment of postoperative sore throat at rest and on swallowing.

    Incidence of postoperative sore throat. Assessment of severity of postoperative sorethroat using scoring system, 0-No sore throat at any time since the operation,1- Minimal sore throat,2- Moderate sore throat,3- Severe sore throat

    From 1 to 24 hr following surgery

Secondary Outcomes (1)

  • -Assessment of post operative cough. Assessment of post operative cough using scoring system,0- No cough,1- Minimal cough,2- Moderate cough,3- Severe cough.

    From 1 to 24 hr following surgery

Study Arms (4)

Group LD: Lidocaine and Dexamethasone

EXPERIMENTAL

lidocaine 1.5 mg/kg and dexamethasone (dexona) 8 mg iv prior to induction of anesthesia

Drug: LD: Lidocaine and dexamethasone

Group L: Lidocaine

ACTIVE COMPARATOR

Group L: lidocaine 1.5 mg/kg iv prior to induction of anesthesia

Drug: L:Lidocaine

D: Dexamethasone

ACTIVE COMPARATOR

Dexamethasone 8 mg iv prior to induction of anesthesia

Drug: D: Dexamethasone

N: normal saline

PLACEBO COMPARATOR

N: normal saline (placebo): 2 ml

Drug: N: Normal saline (placebo)

Interventions

LD: intravenous lidocaine 1.5 mg/kg and dexamethasone 8 mg before induction of anesthesia

Also known as: Xylocard, dexona
Group LD: Lidocaine and Dexamethasone

Intravenous lidocaine 1.5 mg/kg before induction of anesthesia

Also known as: Xylocard
Group L: Lidocaine

D:intravenous dexamethasone 8 mg before induction of anesthesia

Also known as: Dexona
D: Dexamethasone

Normal saline: 2ml

N: normal saline

Eligibility Criteria

Age18 Years - 65 Years
Sexall
Healthy VolunteersNo
Age GroupsAdult (18-64), Older Adult (65+)

You may qualify if:

  • Patients of American Society of Anesthesiologist(ASA) physical status 1 \& 2 requiring general anesthesia with endotracheal intubation.
  • Duration of surgery more than 90 min

You may not qualify if:

  • Those with preexisting hoarseness or sorethroat
  • Smoker
  • Vocal performer by occupation
  • Recent or recurrent respiratory tract infection
  • Risk factors for postoperative aspiration
  • Obesity
  • Pregnancy
  • Receiving analgesics, corticosteroids and calcium channel blockers
  • Contraindication to corticosteroid medications
  • Anticipated difficult intubation
  • Mallampati grade \> 2
  • Difficult mask ventilation requiring oral or nasal airway
  • Cormack and Lehman grade III and IV on laryngoscopy
  • More than one intubation attempt
  • Those requiring orogastric or nasogastric tubes

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

BP Koirala Institute of Health Sciences (BPKIHS)

Dharān, Koshi, 56700, Nepal

Location

Related Publications (1)

  • Subedi A, Tripathi M, Pokharel K, Khatiwada S. Effect of Intravenous Lidocaine, Dexamethasone, and Their Combination on Postoperative Sore Throat: A Randomized Controlled Trial. Anesth Analg. 2019 Jul;129(1):220-225. doi: 10.1213/ANE.0000000000003842.

MeSH Terms

Conditions

CoughHoarseness

Interventions

Dexamethasone

Condition Hierarchy (Ancestors)

Respiration DisordersRespiratory Tract DiseasesSigns and Symptoms, RespiratorySigns and SymptomsPathological Conditions, Signs and SymptomsVoice DisordersLaryngeal DiseasesOtorhinolaryngologic DiseasesNeurologic ManifestationsNervous System Diseases

Intervention Hierarchy (Ancestors)

PregnadienetriolsPregnadienesPregnanesSteroidsFused-Ring CompoundsPolycyclic CompoundsSteroids, Fluorinated

Study Officials

  • Asish Subedi, MD

    BPKIHS

    PRINCIPAL INVESTIGATOR

Study Design

Study Type
interventional
Phase
phase 4
Allocation
RANDOMIZED
Masking
TRIPLE
Who Masked
PARTICIPANT, CARE PROVIDER, INVESTIGATOR
Purpose
TREATMENT
Intervention Model
PARALLEL
Sponsor Type
OTHER
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
Associate Professor, Department of Anesthesiology, BPKIHS

Study Record Dates

First Submitted

November 2, 2013

First Posted

November 21, 2013

Study Start

December 1, 2013

Primary Completion

December 1, 2015

Study Completion

January 1, 2016

Last Updated

November 7, 2016

Record last verified: 2016-11

Locations